NDC 72934-2112

HYDROCORTISONE 2.5% / KETOCONAZOLE 2%

Hydrocortisone 2.5% / Ketoconazole 2%

HYDROCORTISONE 2.5% / KETOCONAZOLE 2% is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Hydrocortisone; Ketoconazole.

Product ID72934-2112_89026ad5-ed04-5058-e053-2a95a90ad2b0
NDC72934-2112
Product TypeHuman Prescription Drug
Proprietary NameHYDROCORTISONE 2.5% / KETOCONAZOLE 2%
Generic NameHydrocortisone 2.5% / Ketoconazole 2%
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2019-05-17
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameHYDROCORTISONE; KETOCONAZOLE
Active Ingredient Strength3 g/100g; g/100g
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Azole Antifungal [EPC],Azoles [CS],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A5 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-2112-2

30 g in 1 BOTTLE, PUMP (72934-2112-2)
Marketing Start Date2019-05-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-2112-2 [72934211202]

HYDROCORTISONE 2.5% / KETOCONAZOLE 2% CREAM
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2019-05-17

Drug Details

Active Ingredients

IngredientStrength
HYDROCORTISONE2.5 g/100g

OpenFDA Data

SPL SET ID:89026ad5-ed03-5058-e053-2a95a90ad2b0
Manufacturer
UNII

Pharmacological Class

  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Azole Antifungal [EPC]
  • Azoles [CS]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytochrome P450 3A5 Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Azole Antifungal [EPC]
  • Azoles [CS]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytochrome P450 3A5 Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.